MPX International Corporation (“
MPX
International”, “
MPXI” or the
“
Corporation”) (CSE:MPXI; OTCQX:MPXOF), a
multinational diversified cannabis company, is pleased to announce
that it intends to further operationalize some of its
revenue-generating assets and is raising a minimum of C$4.0 million
and a maximum of C$5.0 million in a non-brokered private placement
offering (the “
Offering”) of a minimum of 3,000
units (the “
Units”) and a maximum of 3,700 Units
at a price of US$1,000.00 per Unit.
“This fund raise will
enable the final stage of development of our
processing operations in Switzerland and the launch of a
number of new CBD products into that market in the coming months,
including oils, smokables and pouches and to advance other cannabis
projects in Canada and globally. The revenue from these capital
expenditures will have the potential to create a significant impact
on our near-term revenue generation,” said W. Scott Boyes,
Chairman, President and CEO of MPXI. “At the same time, we have
instigated cost saving measures across the corporate group in order
to accelerate the path to sustainable long-term profitability.”
Each Unit consists of
one 12% secured convertible debenture of the Corporation (a
“Debenture”) in the principal amount of
US$1,000.00 (the “Principal Amount”) and 7,000
common share purchase warrants (each, a
“Warrant”). The Debentures will have a maturity
date of twenty-four (24) months from the date of issuance, subject
to certain conversion privileges (the “Maturity
Date”) as set forth in a debenture indenture (the
“Debenture Indenture”) with AST Trust Company
(Canada) (“AST”). Each Debenture will
rank pari passu in right of payment of principal and
interest with all other Debentures issued under the Offering.
The Corporation intends to use the proceeds from
the Offering to fund product and facility development in
Switzerland and retail expansion in Canada as well as for working
capital and other general corporate purposes.
The closing of the Offering is subject to the
receipt of any necessary regulatory approvals, including, to the
extent necessary, the approval of the CSE and may occur in multiple
tranches.
Each Debenture shall
bear interest at a rate of 12% per annum from the date of issue,
payable quarterly in arrears on the last day of March, June,
September and December in each year, commencing December 31, 2020
(each, a “Coupon Date”). The amount of interest
that becomes payable on December 31, 2020 will represent accrued
interest for the period from the Initial Closing Date to December
31, 2020. All accrued but unpaid interest as of each Coupon Date
shall be payable by the Corporation in cash and shall accrue
interest at a rate of 12% per annum.
The Principal Amount,
shall be convertible, for no additional consideration, into common
shares of the Corporation (the “Common Shares”) at
the option of the holder at any time prior to the earlier of: (i)
6:00 p.m. (Eastern Standard Time) on the Maturity Date; or (ii) the
business day immediately preceding the date specified by MPXI for
redemption of the Debentures at a conversion price equal to C$0.12
per Common Share.
Each Warrant entitles
the holder thereof to purchase one Common Share (each, a
“Warrant Share”) at an exercise price of C$0.20
(the “Exercise Price”) for a period of twenty-four
(24) months from the Closing Date (the “Expiry
Date”). The Corporation and AST will enter into a warrant
indenture (the “Warrant Indenture”) pursuant to
which the Warrants will be created and issued.
It is a condition of the Offering that the
Corporation execute and deliver a guarantee and certain security
documents in favour of AST, as collateral agent, as security for
the payment and performance of the Corporation’s obligations under
the Debenture Indenture.
The Corporation may pay a cash placement fee
equal to 5% of the aggregate gross proceeds paid by each purchaser
of Units that are invested in the Offering excluding the aggregate
number of Units purchased by investors that participated in the
Corporation’s prior equity raise which closed in March 2019.
In addition, the Corporation may issue that
number of common share purchase warrants (the “Compensation
Warrants”) equal to 5% of the aggregate number of Common
Shares underlying the Debentures if converted as of the Closing
Date and the Warrants issued to purchasers of the Units excluding
the aggregate number Units purchased by investors that participated
in the Corporation’s equity raise which closed in March 2019. The
Compensation Warrants shall be exercisable at the Exercise Price
for a period of two (2) years from the applicable Closing Date of
the Offering.
The securities issued pursuant to the Offering
including any Common Shares and other underlying securities issued
on conversion of the securities will be subject to a statutory hold
period in Canada of four months and one day following the
applicable closing date of the Offering in accordance with
applicable securities laws. Additional resale restriction may be
applicable under the laws of other jurisdictions.
This news release does not constitute an offer
to sell or a solicitation of an offer to buy any of the securities
described herein, and these securities will not be offered or sold
in any jurisdiction in which their offer or sale would be unlawful.
The securities have not been and will not be registered under the
U.S. Securities Act, or any state securities laws of the United
States. Accordingly, these securities will not be offered or sold
to persons within the United States unless an exemption from the
registration requirements of the U.S. Securities Act and applicable
state securities laws is available.
About MPX International
Corporation
MPX International Corporation is a multinational
diversified cannabis company focused on developing and operating
assets across the global cannabis industry with an emphasis on
cultivating, manufacturing and marketing products which include
cannabinoids as their primary active ingredient.
Cautionary Statement Regarding
Forward-Looking Information This news release includes
certain “forward-looking statements” under applicable Canadian
securities legislation that are not historical facts.
Forward-looking statements involve risks, uncertainties, and other
factors that could cause actual results, performance, prospects,
and opportunities to differ materially from those expressed or
implied by such forward-looking statements. Forward-looking
statements in this news release include, but are not limited to,
MPX International’s objectives and intentions. Forward-looking
statements are necessarily based on a number of estimates and
assumptions that, while considered reasonable, are subject to known
and unknown risks, uncertainties and other factors which may cause
actual results and future events to differ materially from those
expressed or implied by such forward-looking statements. Such
factors include, but are not limited to: general business, economic
and social uncertainties; litigation, legislative, environmental
and other judicial, regulatory, political and competitive
developments; delay or failure to receive board, shareholder or
regulatory approvals; those additional risks set out in MPX
International’s public documents filed on SEDAR
at www.sedar.com, including its audited annual consolidated
financial statements for the financial years ended September 30,
2019 and 2018 and the corresponding annual management’s discussion
and analysis; and other matters discussed in this news release.
Although MPX International believes that the assumptions and
factors used in preparing the forward-looking statements are
reasonable, undue reliance should not be placed on these
statements, which only apply as of the date of this news release,
and no assurance can be given that such events will occur in the
disclosed time frames or at all. Except where required by law, MPX
International disclaims any intention or obligation to update or
revise any forward-looking statement, whether as a result of new
information, future events, or otherwise.
For further information, please contact:
MPX International Corporation W. Scott Boyes, Chairman,
President and CEOT: +1-416-840-3725
info@mpxinternationalcorp.com
For additional information on MPXI visit our
website www.mpxinternationalcorp.com or http://mpxi.tv.
MPX (CSE:MPXI)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
MPX (CSE:MPXI)
Historical Stock Chart
Von Jan 2024 bis Jan 2025